Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.

Article Details

Citation

Biegel A, Gebauer S, Hartrodt B, Brandsch M, Neubert K, Thondorf I

Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.

J Med Chem. 2005 Jun 30;48(13):4410-9.

PubMed ID
15974593 [ View in PubMed
]
Abstract

The utilization of the membrane transport protein PEPT1 as a drug delivery system is a promising strategy to enhance the oral bioavailability of drugs. Since very little is known about the substrate binding site of PEPT1, computational methods are a meaningful tool to gain a more detailed insight into the structural requirements for substrates. Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using the comparative molecular similarity indices analysis (CoMSIA) method were performed on a training set of 98 compounds. Affinity constants of beta-lactam antibiotics and tripeptides were determined at Caco-2 cells. A statistically reliable model of high predictive power was obtained (q(2) = 0.828, r(2) = 0.937). The results derived from CoMSIA were graphically interpreted using different field contribution maps. We identified those regions which are crucial for the interaction between peptidomimetics and PEPT1. The new 3D-QSAR model was used to design a new druglike compound mimicking a dipeptide. The predicted K(i) value was confirmed experimentally.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
PhenoxymethylpenicillinSolute carrier family 15 member 1ProteinHumans
Unknown
Not AvailableDetails
Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
AmpicillinSolute carrier family 15 member 1Ki (nM)15000000N/AN/ADetails
BenzylpenicillinSolute carrier family 15 member 1Ki (nM)>30000000N/AN/ADetails
CefaclorSolute carrier family 15 member 1Ki (nM)>10000000N/AN/ADetails
CefadroxilSolute carrier family 15 member 1Ki (nM)7200000N/AN/ADetails
CefalotinSolute carrier family 15 member 1Ki (nM)>10000000N/AN/ADetails
CefepimeSolute carrier family 15 member 1Ki (nM)>30000000N/AN/ADetails
CefiximeSolute carrier family 15 member 1Ki (nM)12000000N/AN/ADetails
CefmetazoleSolute carrier family 15 member 1Ki (nM)28000000N/AN/ADetails
CefotaximeSolute carrier family 15 member 1Ki (nM)>30000000N/AN/ADetails
CefradineSolute carrier family 15 member 1Ki (nM)9800000N/AN/ADetails
CeftibutenSolute carrier family 15 member 1Ki (nM)340000N/AN/ADetails
CeftriaxoneSolute carrier family 15 member 1Ki (nM)>30000000N/AN/ADetails
CefuroximeSolute carrier family 15 member 1Ki (nM)26000000N/AN/ADetails
CephalexinSolute carrier family 15 member 1Ki (nM)14000000N/AN/ADetails
CloxacillinSolute carrier family 15 member 1Ki (nM)2500000N/AN/ADetails
CyclacillinSolute carrier family 15 member 1Ki (nM)500000N/AN/ADetails
DicloxacillinSolute carrier family 15 member 1Ki (nM)7200000N/AN/ADetails
OxacillinSolute carrier family 15 member 1Ki (nM)12000000N/AN/ADetails
PhenoxymethylpenicillinSolute carrier family 15 member 1Ki (nM)21000000N/AN/ADetails